Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin for MI primary prevention

Executive Summary

Use of aspirin for primary prevention of myocardial infarction will be considered by FDA's Cardiovascular & Renal Drugs Advisory Committee in consultation with Nonprescription Drugs Advisory Committee on Dec. 8. Bayer asked FDA in a Feb. 11 citizen petition to allow the indication based on a meta-analysis of five studies showing a 32% reduction in MI in patients who had not previously had a cardiovascular event. The meeting will be held at the Hilton in Gaithersburg, Md. beginning at 8:30 a.m. [To 1watch a webcast of the meeting, go to FDAAdvisoryCommittee.com]...

You may also be interested in...



Fines, But No Prison Time For Ex-Acclarent Execs

The sentences are the latest chapter in a long-running off-label marketing case.

RedHill Could Soon Seek EUA For COVID-19 Therapy

The Israel-based, NASDAQ-listed biotech tells Scrip that if the oral SK2 selective inhibitor succeeds in a Phase II/III study, it would be "very comfortable" taking opaganib all the way to market on its own.

Beximco Takes Control Of Sanofi Bangladesh

Beximco has struck a deal worth nearly $50m to acquire a majority stake in Sanofi Bangladesh, allowing the firm to expand in its domestic market.

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel